rocatinlimab
Amgen,Kyowa Kirin
[]
breaking news @ #eadvcongress fr/ : rocatinlimab, an anti-ox40 monoclonal antibody, shows long-term, durable improvement in markers of inflammation, &amp; signs &amp; symptoms of #eczema. benefits persist after stopping treatment! need to learn more about side effect profile 
Grassroots, parent-run nonprofit that advances research on pediatric #eczema & improves quality of life for families. Host of @eczemabreakthroughs Podcast!